Enteroptyx

Enteroptyx is a biotechnology company focused on the development of precision molecular imaging technologies for the diagnosis and management of gastrointestinal diseases. Spun out of the Mayo Clinic, the company utilizes fluorescently labeled probes to visualize molecular markers of inflammation in real-time during endoscopic procedures. This technology is designed to provide objective assessments of mucosal healing and disease activity in patients with Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. By bridging the gap between conventional endoscopy and molecular pathology, Enteroptyx aims to enable more personalized and effective treatment strategies for GI patients.